ABT
57
-5
EW
37
-2
GIS
26
3
KR
34
-3
CSX
51
-2
EXR
57
-2
CMCSA
48
2
DVA
72
2
XYL
37
2
WDC
41
-2
AES
39
-4
DAL
80
-4
GRMN
62
-3
OXY
40
3
DNB
78
6
TRV
53
-3
EFX
32
2
COST
58
-2
K
53
2
HPE
55
11
ABT
57
-5
EW
37
-2
GIS
26
3
KR
34
-3
CSX
51
-2
EXR
57
-2
CMCSA
48
2
DVA
72
2
XYL
37
2
WDC
41
-2
AES
39
-4
DAL
80
-4
GRMN
62
-3
OXY
40
3
DNB
78
6
TRV
53
-3
EFX
32
2
COST
58
-2
K
53
2
HPE
55
11
Financhill
Back

Assembly Biosciences 10K Form

Sell
36

ASMB
Assembly Biosciences

Last Price:
14.79
Seasonality Move:
9.02%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive ASMB News And Ratings

See the #1 stock for the next 7 days that we like better than ASMB

ASMB Financial Statistics

Sales & Book Value

Annual Sales: $7.16M
Cash Flow: $-15.24M
Price / Cash Flow: 3.95
Annual Sales: $4.09
Price / Book: 3.87

Profitability

EPS (TTM): -6.92000
Net Income (TTM): $-40.8M
Gross Margin: $0
Return on Equity: -115.86%
Return on Assets: -38.94%

Assembly Biosciences Earnings Forecast

Key Assembly Biosciences Financial Ratios

  • The Selling, General & Administrative Expenses for ASMB have been equal to 319.82% of Gross Profit Margin.
  • The Research & Development expenses have been 682.67% of Revenue.
  • The Interest Expense is 0.00% of Operating Income.
  • Per Share Earnings over the last 16 years have been positive in 11 years.

Assembly Biosciences Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: ASMB
CUSIP: 045396
Website: assemblybio.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 2.36
Quick Ratio: 2.28

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

ASMB Technical Analysis vs Fundamental Analysis

Sell
36
Assembly Biosciences (ASMB) is a Sell

Is Assembly Biosciences a Buy or a Sell?